Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Dobrich

25 clinical trials in Dobrich, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dobrich at a glance
25
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

25 trials in Dobrich

Open in trial search

Colorectal cancer+1

Recruiting

Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST GDNF FAMILY RECEPTOR ALPHA-LIKE
  • Sponsor:Ngm Biopharmaceuticals Inc.

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Graves' disease

Recruiting

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Breast cancer+2

Not yet recruiting

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Laboratorios Farmaceuticos Rovi S.A.

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Metsera Inc.

Psoriasis

Not recruiting

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Dobrich

What the registry says about research in the country

01 Cardiovascular and Metabolic Research

Clinical investigations focusing on cardiovascular diseases and metabolic conditions, including innovative treatments for obesity and atherosclerosis. Studies evaluate new therapies for improving cardiovascular outcomes and managing metabolic disorders.

  • Obesity Management
  • Atherosclerotic Disease
  • Type 2 Diabetes

Research aims to advance treatment options for patients with complex cardiometabolic conditions.

02 Respiratory Medicine

Groundbreaking research in pulmonary diseases, with particular focus on COPD and lung cancer treatments. Studies evaluate combination therapies and novel approaches for managing chronic respiratory conditions.

  • COPD Treatment
  • Non-Small Cell Lung Cancer
  • Respiratory Health

Investigations aim to improve quality of life for patients with chronic respiratory conditions.

03 Nephrology Studies

Advanced research in kidney diseases and related conditions, exploring new treatments for chronic kidney disease and complications in dialysis patients. Studies focus on both diabetic and non-diabetic kidney conditions.

  • Chronic Kidney Disease
  • Dialysis Complications
  • Renal Protection

Trials aim to improve outcomes for patients with various forms of kidney disease.

04 Immunology and Inflammation

Innovative research in autoimmune conditions and inflammatory diseases, including studies on rheumatoid arthritis and ulcerative colitis. Trials evaluate both novel therapies and biosimilar treatments.

  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Allergic Conditions

Studies focus on developing more effective treatments for chronic inflammatory conditions.

05 Oncology Research

Cutting-edge studies in cancer treatment, with a focus on breast cancer and advanced lung cancer. Research includes evaluation of targeted therapies and immunotherapy approaches.

  • Breast Cancer Therapy
  • Lung Cancer Treatment
  • Immunotherapy

Trials aim to improve survival rates and treatment outcomes in cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.